Consistently, overexpression of NEK6 has also been linked to the etiology and progression of several cancers, including osteosarcoma, breast cancer, prostate cancer, hepatocellular carcinoma, colon cancer, gastric cancer, and ovarian cancer (Figure 3; Table 4). Here, NEK6 is linked to osteosarcoma.